0:42 Introduction 2:10 Opening remarks 7:14 An overview of and Historical Review on BNCT Part1: Clinical aspects of BNCT 33:26 P1.a: The path of BNCT to a reimbursement 50:04 P1.b: Imaging and patient positioning 1:03:33 P1.c: Treatment Planning for BNCT 1:27:02 P1.d: Status of BNCT in Japan Part2: Industrial aspects of BNCT 1:44:10 P2.a: Sumitomo Heavy Industries Presentation 1:58:19 P2.b: Neutron Therapeutics presentation 2:11:36 P2.c: Recent BNCT drug development and use overview 2:22:00 P2.d: TAE Life Sciences presentation 2:43:00 Conclusion
Пікірлер: 1